Dhaval Desai

Dhaval Desai

Corporate Officer/Principal bij 4D MOLECULAR THERAPEUTICS, INC.
Health Technology
Consumer Services
Commercial Services

Profiel

Dhaval Desai currently works at 4D Molecular Therapeutics, Inc., as Chief Development Officer from 2024.
Dr. Desai also formerly worked at Thrombogenics, Inc., as Global Director-Medical Affairs from 2011 to 2014, Aerpio Therapeutics, Inc., as Vice President-Medical Affairs, Novartis AG, as Vice President & Head-US Ophthalmics from 2018 to 2020, Aerpio Pharmaceuticals, Inc., as Chief Strategy Officer & VP-Medical Affairs from 2014 to 2018, and IVERIC bio, Inc., as Chief of Staff from 2020 to 2021.
Dr. Desai received his doctorate degree from Rutgers State University of New Jersey.

Actieve functies van Dhaval Desai

BedrijvenFunctieBegin
4D MOLECULAR THERAPEUTICS, INC. Corporate Officer/Principal 25-09-2024

Eerdere bekende functies van Dhaval Desai

BedrijvenFunctieEinde
NOVARTIS AG Corporate Officer/Principal 01-08-2020
AERPIO PHARMACEUTICALS Hoofd Techniek/Wetenschap/O&O -
Corporate Officer/Principal 01-07-2014
IVERIC BIO, INC. Human Resources Officer 01-04-2021
Hoofd Techniek/Wetenschap/O&O -
Ervaring van Dhaval Desai in detail bekijken

Opleiding van Dhaval Desai

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

15

Eerstegraads connecties

7

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit7

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Commercial Services

Health Technology

  1. Beurs
  2. Insiders
  3. Dhaval Desai